161 related articles for article (PubMed ID: 19875511)
21. Interaction of HIV-1 integrase with polypyrimidine tract binding protein and associated splicing factor (PSF) and its impact on HIV-1 replication.
Yadav P; Sur S; Desai D; Kulkarni S; Sharma V; Tandon V
Retrovirology; 2019 Apr; 16(1):12. PubMed ID: 31036027
[TBL] [Abstract][Full Text] [Related]
22. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
Duan L; Zhu M; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 latency due to the site of proviral integration.
Winslow BJ; Pomerantz RJ; Bagasra O; Trono D
Virology; 1993 Oct; 196(2):849-54. PubMed ID: 8372452
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 replication by targeting the Rev protein.
Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
[TBL] [Abstract][Full Text] [Related]
25. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.
Iversen AK; Shpaer EG; Rodrigo AG; Hirsch MS; Walker BD; Sheppard HW; Merigan TC; Mullins JI
J Virol; 1995 Sep; 69(9):5743-53. PubMed ID: 7637019
[TBL] [Abstract][Full Text] [Related]
26. Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition.
Wu Y; Duan L; Zhu M; Hu B; Kubota S; Bagasra O; Pomerantz RJ
J Virol; 1996 May; 70(5):3290-7. PubMed ID: 8627813
[TBL] [Abstract][Full Text] [Related]
27. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes.
Malim MH; Cullen BR
Mol Cell Biol; 1993 Oct; 13(10):6180-9. PubMed ID: 8105371
[TBL] [Abstract][Full Text] [Related]
28. Positive and negative modulation of human immunodeficiency virus type 1 Rev function by cis and trans regulators of viral RNA splicing.
Pongoski J; Asai K; Cochrane A
J Virol; 2002 May; 76(10):5108-20. PubMed ID: 11967326
[TBL] [Abstract][Full Text] [Related]
29. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of the HIV-1 integrase enzymatic activity and cDNA integration by a peptide derived from the integrase protein.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
Biopolymers; 2010 Aug; 93(8):740-51. PubMed ID: 20517955
[TBL] [Abstract][Full Text] [Related]
31. Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.
Bevec D; Volc-Platzer B; Zimmermann K; Dobrovnik M; Hauber J; Veres G; Böhnlein E
Hum Gene Ther; 1994 Feb; 5(2):193-201. PubMed ID: 8186299
[TBL] [Abstract][Full Text] [Related]
32. Expression of human immunodeficiency virus 1 (HIV-1) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells.
Bird C; Burke J; Gleeson PA; McCluskey J
J Biol Chem; 1990 Nov; 265(31):19151-7. PubMed ID: 2229068
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 Gag Forms Ribonucleoprotein Complexes with Unspliced Viral RNA at Transcription Sites.
Tuffy KM; Maldonado RJK; Chang J; Rosenfeld P; Cochrane A; Parent LJ
Viruses; 2020 Nov; 12(11):. PubMed ID: 33182496
[TBL] [Abstract][Full Text] [Related]
34. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
35. The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions.
Hakata Y; Yamada M; Mabuchi N; Shida H
J Virol; 2002 Aug; 76(16):8079-89. PubMed ID: 12134013
[TBL] [Abstract][Full Text] [Related]
36. Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev.
Wu BY; Woffendin C; MacLachlan I; Nabel GJ
J Virol; 1997 Apr; 71(4):3161-7. PubMed ID: 9060679
[TBL] [Abstract][Full Text] [Related]
37. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.
Yamada O; Kraus G; Luznik L; Yu M; Wong-Staal F
J Virol; 1996 Mar; 70(3):1596-601. PubMed ID: 8627679
[TBL] [Abstract][Full Text] [Related]
38. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
[TBL] [Abstract][Full Text] [Related]
39. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
40. Regulation of human retroviral latency by the NF-kappa B/I kappa B family: inhibition of human immunodeficiency virus replication by I kappa B through a Rev-dependent mechanism.
Wu BY; Woffendin C; Duckett CS; Ohno T; Nabel GJ
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1480-4. PubMed ID: 7878004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
